Dinçer, B. T., Usta, A. M., Kural, A., Helvacı, N., Uçar, A., & Urgancı, N. Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents? BMC.
Chicago Style (17th ed.) CitationDinçer, Büşra Tetik, Ayşe Merve Usta, Alev Kural, Nazlı Helvacı, Ahmet Uçar, and Nafiye Urgancı. Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease in Obese Adolescents? BMC.
MLA (9th ed.) CitationDinçer, Büşra Tetik, et al. Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease in Obese Adolescents? BMC.
Warning: These citations may not always be 100% accurate.